In recent years, vitreoretinal surgery has been revolutionized by extremely relevant technological improvements. A progressive reduction in the instruments gauge and great improvements in lighting devices, panoramic view systems and intraocular tamponades demonstrate the progressive tendency to make the vitreoretinal surgery progressively less traumatic and more effective in treating an ever wider number of pathologies. On the other hand, surgeon's expertise have become more and more extensive and the patient's prognosis have benefited from the introduction of new techniques. For this reason, it’s crucial that good ideas and novel insights are shared among surgeons.
Despite these great technological advances, some conditions continue to represent a challenge for vitreoretinal surgeons. Just to name a few of them, myopic tractive maculopathy, proliferative vitreoretinopathy (PVR), severe diabetic retinopathy, macular hemorrhages and traumas, are still affected by high rates of complications and an elevated risk of recurrence. A deeper knowledge of the pathophysiological mechanisms of these conditions is needed, in addition to pharmacological adjuvants, in order to improve surgical outcomes.
The aim of this Research Topic is to present a wide range of innovations in the field of vitreoretinal surgery: thus, we encourage authors to submit manuscripts covering basic research right through to the descriptions of intriguing clinical cases. Above all, we encourage authors to “think out of the box” and contribute to a fervent debate among the surgeon community.
In recent years, vitreoretinal surgery has been revolutionized by extremely relevant technological improvements. A progressive reduction in the instruments gauge and great improvements in lighting devices, panoramic view systems and intraocular tamponades demonstrate the progressive tendency to make the vitreoretinal surgery progressively less traumatic and more effective in treating an ever wider number of pathologies. On the other hand, surgeon's expertise have become more and more extensive and the patient's prognosis have benefited from the introduction of new techniques. For this reason, it’s crucial that good ideas and novel insights are shared among surgeons.
Despite these great technological advances, some conditions continue to represent a challenge for vitreoretinal surgeons. Just to name a few of them, myopic tractive maculopathy, proliferative vitreoretinopathy (PVR), severe diabetic retinopathy, macular hemorrhages and traumas, are still affected by high rates of complications and an elevated risk of recurrence. A deeper knowledge of the pathophysiological mechanisms of these conditions is needed, in addition to pharmacological adjuvants, in order to improve surgical outcomes.
The aim of this Research Topic is to present a wide range of innovations in the field of vitreoretinal surgery: thus, we encourage authors to submit manuscripts covering basic research right through to the descriptions of intriguing clinical cases. Above all, we encourage authors to “think out of the box” and contribute to a fervent debate among the surgeon community.